Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ventracid-Repha is a multi-ingredient dietary supplement developed and marketed by Repha GmbH in Germany, specifically formulated to support digestive health and fat metabolism. The product contains rizolipase (a plant-based lipase concentrate from Japanese rice fungus) to aid in the breakdown of dietary fats, curcuma (turmeric) root extract to stimulate liver and gallbladder function, sodium bicarbonate to buffer excess stomach acid, and choline bitartrate to support normal fat metabolism and liver function. It is available as film-coated tablets and is primarily used to address digestive issues related to fat intake and acid balance. As a dietary supplement rather than a pharmaceutical drug, it is available over-the-counter in German pharmacies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ventracid-Repha.